Top journals
Frequent coauthors
- Weill A 5
- Zureik M 5
- Noémie Roland 4
- Hoisnard L 4
- Lise Duranteau 4
- Passeri T 3
- Neumann A 3
- Joël Coste 3
- Baricault B 2
- Nguyen P 2
2025
ObjectiveTo assess the risk of intracranial meningioma associated with oral contraceptives containing desogestrel, levonorgestrel, or levonorgestrel combined with oestrogen.DesignCase-control study.SettingFrench national health data system …
2025
Background and purposeChlormadinone acetate (CMA) is a synthetic progestin for which cases of intracranial meningioma have been reported following prolonged exposure.MethodAn observational cohort study was conducted based on the French nati…
2025
IntroductionExogenous and endogenous sex hormones, especially Progesterone agonists, may be causally linked to meningioma progression. Cessation of treatment leads to stabilization or regression of Progestin-induced meningioma. In many case…
2024
BackgroundNomegestrol acetate (NOMAC) is a synthetic potent progestogen. This study aimed to assess the risk of intracranial meningioma associated with the prolonged use of NOMAC.MethodsObservational cohort study using SNDS data (France). W…
2024
ObjectiveTo assess the risk of intracranial meningioma associated with the use of selected progestogens.DesignNational case-control study.SettingFrench National Health Data System (ie, Système National des Données de Santé).ParticipantsOf 1…
2022
Background and purposeA dose-dependent association between the use of cyproterone acetate (CPA) and intracranial meningioma has been identified but data for other potent progestogens are scarce. The association was assessed between intracra…